Scientific Reports (Sep 2024)

Risk factors and prognostic impact of unwanted loneliness in heart failure

  • Teresa Benito,
  • Georgiana Zaharia,
  • Adora Pérez,
  • Cristina Jaramillo,
  • Miguel Lorenzo,
  • Anna Mollar,
  • Carolina Martínez,
  • Evelin Bejarano,
  • Francisco Cebrián,
  • Jose Civera,
  • Julio Núñez

DOI
https://doi.org/10.1038/s41598-024-72847-5
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Heart failure (HF) is associated with a high prevalence of unwanted loneliness. This study aimed to assess whether unwanted loneliness was associated with adverse clinical endpoints in HF patients. Additionally, we also aimed to examine the risk factors associated with unwanted loneliness in HF. We included 298 patients diagnosed with stable HF. Clinical, biochemical, echocardiographic parameters and loneliness using ESTE II scale were assessed. We analyzed the association between the exposure and adverse clinical endpoints by Cox (death or any hospitalization), and negative binomial regressions (recurrent hospitalizations or visits to the emergency room). Risk factors associated with loneliness were analyzed using logistic regression. The mean age was 75.8 ± 9.4 years, with 111 (37.2%) being women, 53 (17.8%) widowed, and 154 (51.7%) patients having preserved ejection fraction. The median (p25–p75%) ESTE II score was 9.0 (6.0–12.0), and 36.9% fulfilled the loneliness criteria (> 10). Both women (OR = 2.09; 95% CI 1.11–3.98, p = 0.023) and widowhood (OR = 3.25; 95% CI 1.51–7.01, p = 0.003) were associated with a higher risk of loneliness. During a median follow-up of follow-up of 362 days (323–384), 93 patients (31.3%) presented the combined episode of death or all-cause admissions. Loneliness was significantly related to the risk of time to the composite of death or any readmission during the composite (HR = 1.83; 95% CI 1.18–2.84, p = 0.007). Women and widowhood emerge as risk factors for unwanted loneliness in HF patients. Unwanted loneliness is associated with higher morbidity during follow-up.

Keywords